KZIA

Kazia Therapeutics (KZIA)

Kazia Therapeutics Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KZIA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/23	22 : 27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/23	22 : 26	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/23	22 : 25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/23	22 : 23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/23	21 : 30	PR Newswire (US)	Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/13	22 : 14	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/13	22 : 12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/13	22 : 10	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/13	22 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/09/12	20 : 30	PR Newswire (US)	KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/08/13	08 : 28	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/07/10	23 : 35	AllPennyStocks.com	Biotech Experiences Strong Open Following Major Announcement	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/07/10	22 : 28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/07/10	22 : 28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/07/10	22 : 26	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/07/10	22 : 19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/07/10	20 : 30	PR Newswire (US)	Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/06/27	21 : 15	PR Newswire (US)	KAZIA ANNOUNCES UPCOMING DIPG DATA PRESENTATIONS AT ISPNO AND PUBLICATION IN EUROPEAN JOURNAL OF CANCER	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/06/05	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/06/05	05 : 06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/29	21 : 55	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/24	03 : 41	PR Newswire (US)	Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/23	20 : 03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/18	05 : 07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/18	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/01	21 : 45	PR Newswire (US)	KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/03/21	21 : 52	PR Newswire (US)	Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/03/13	21 : 00	PR Newswire (US)	Kazia announces presentation of new data at AACR Annual Meeting	NASDAQ:KZIA	Kazia Therapeutics Ltd